Psychedelics as anti-inflammatory agents

A JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Lindemann, L., Jaeschke, G., Michalon, A., Vieira, E., Honer, M., Spooren, W., Porter, R., Hartung, T., Kolczewski, S., Büttelmann, B., et al. (1909) · JAMA · doi:10.1001/jama.1909.02550020033007 · Cited by 7,865 · see citing works

Origin and physiological roles of inflammation

Medzhitov, R. (2008) · Nature · doi:10.1038/nature07201 · Cited by 6,618 · see citing works

Crystal Structure of Rhodopsin: A G Protein-Coupled Receptor

Palczewski, K., Kumasaka, T., Hori, T., Behnke, C. A., Motoshima, H., Fox, B. A., Trong, I. L., Teller, D. C., Okada, T., Stenkamp, R. E., et al. (2000) · Science · doi:10.1126/science.289.5480.739 · Cited by 5,637 · see citing works

How many drug targets are there?

Overington, J. P., Al-Lazikani, B., & Hopkins, A. L. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2199 · Cited by 3,505 · see citing works

International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).

Hoyer, D., Clarke, D. E., Fozard, J. R., Hartig, P. R., Martin, G. R., Mylecharane, E. J., Saxena, P. R., & Humphrey, P. P. A. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06783-3 · Cited by 2,997 · see citing works

The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints

Fredriksson, R., Lagerström, M. C., Lundin, L.-G., & Schiöth, H. B. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.6.1256 · Cited by 2,941 · see citing works

Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene

Samson, M., Libert, F., Doranz, B. J., Rucker, J. B., Liesnard, C., Farber, C., Saragosti, S., Lapouméroulie, C., Cognaux, J., Forceille, C., et al. (1996) · Nature · doi:10.1038/382722a0 · Cited by 2,885 · see citing works

Drug Discovery: A Historical Perspective

Drews, J. (2000) · Science · doi:10.1126/science.287.5460.1960 · Cited by 2,768 · see citing works

Pharmacological Reviews

(2024) · Pharmacological Reviews · doi:10.1124/pr · Cited by 2,680 · see citing works

Overview of the immune response

Chaplin, D. D. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.12.980 · Cited by 2,235 · see citing works

Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial

Griffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., Cosimano, M. P., & Klinedinst, M. A. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675513 · Cited by 2,201 · see citing works

Psychedelics

Nichols, D. E. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.011478 · Cited by 1,762 · see citing works

Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial.

Ross, S., Bossis, A., Guss, J., Agin-Liebes, G., Malone, T., Cohen, B., Mennenga, S. E., Belser, A., Kalliontzi, K., Babb, J., et al. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675512 · Cited by 1,698 · see citing works

Asthma

Busse, W. W., & Lemanske, R. F. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102013440507 · Cited by 1,604 · see citing works

Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study

Carhart-Harris, R. L., Bolstridge, M., Rucker, J., Day, C. M. J., Erritzoe, D., Kaelen, M., Bloomfield, M., Rickard, J. A., Forbes, B., Feilding, A., et al. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30065-7 · Cited by 1,540 · see citing works

Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin

Carhart-Harris, R. L., Erritzoe, D., Williams, T., Stone, J. M., Reed, L. J., Colasanti, A., Tyacke, R. J., Leech, R., Malizia, A. L., Murphy, K., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1119598109 · Cited by 1,172 · see citing works

Functional Selectivity and Classical Concepts of Quantitative Pharmacology

Urban, J. D., Clarke, W. P., von Zastrow, M., Nichols, D. E., Kobilka, B. K., Weinstein, H., Javitch, J. A., Roth, B. L., Christopoulos, A., Sexton, P. M., et al. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.104463 · Cited by 1,119 · see citing works

Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action

Vollenweider, F. X., Vollenweider-Scherpenhuyzen, M. F. I., Bäbler, A., Vogel, H., & Hell, D. (1998) · NeuroReport · doi:10.1097/00001756-199812010-00024 · Cited by 1,018 · see citing works

Psilocybin with psychological support for treatment-resistant depression: six-month follow-up

Carhart-Harris, R. L., Bolstridge, M., Day, C. M. J., Rucker, J., Watts, R., Erritzoe, D. E., Kaelen, M., Giribaldi, B., Bloomfield, M., Pilling, S., et al. (2018) · Psychopharmacology · doi:10.1007/s00213-017-4771-x · Cited by 970 · see citing works

Serotonin Receptors

Nichols, D. E., & Nichols, C. D. (2008) · Chemical Reviews · doi:10.1021/cr078224o · Cited by 895 · cited 1× · see citing works

Neural correlates of the LSD experience revealed by multimodal neuroimaging

Carhart-Harris, R. L., Muthukumaraswamy, S., Roseman, L., Kaelen, M., Droog, W., Murphy, K., Tagliazucchi, E., Schenberg, E. E., Nest, T., Orban, C., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1518377113 · Cited by 859 · see citing works

The prevalence of severe refractory asthma

Hekking, P.-P. W., Wener, R. R. L., Amelink, M., Zwinderman, A. H., Bouvy, M. L., & Bel, E. H. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.08.042 · Cited by 815 · see citing works

Neuroinflammation and psychiatric illness

Najjar, S., Pearlman, D. M., Alper, K., Najjar, A., & Devinsky, O. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-43 · Cited by 733 · see citing works

PIHKAL: A Chemical Love Story

Shulgin, A. T., & Shulgin, A. (1991) · Cited by 668 · see citing works

Inflammation and clinical response to treatment in depression: A meta-analysis

Strawbridge, R., Arnone, D., Danese, A., Papadopoulos, A., Herane Vives, A., & Cleare, A. J. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.06.007 · Cited by 666 · see citing works

5-HT3 receptors are membrane ion channels

Derkach, V. A., Surprenant, A., & NORTH, R. A. (1989) · Nature · doi:10.1038/339706a0 · Cited by 630 · see citing works

An introduction to immunology and immunopathology

Warrington, R., Watson, W. T. A., Kim, H. L., & Antonetti, F. R. (2011) · Allergy Asthma and Clinical Immunology · doi:10.1186/1710-1492-7-s1-s1 · Cited by 595 · see citing works

The many paths to asthma: phenotype shaped by innate and adaptive immunity

Kim, H. Y., DeKruyff, R. H., & Umetsu, D. T. (2010) · Nature Immunology · doi:10.1038/ni.1892 · Cited by 588 · see citing works

Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms

Carhart-Harris, R. L., Roseman, L., Bolstridge, M., Demetriou, L., Pannekoek, J. N., Wall, M. B., Tanner, M., Kaelen, M., McGonigle, J., Murphy, K., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-13282-7 · Cited by 587 · see citing works

The immune system and developmental programming of brain and behavior

Bilbo, S. D., & Schwarz, J. M. (2012) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2012.08.006 · Cited by 579 · see citing works

How Ligands Illuminate GPCR Molecular Pharmacology

Wacker, D., Stevens, R. C., & Roth, B. L. (2017) · Cell · doi:10.1016/j.cell.2017.07.009 · Cited by 560 · see citing works

Increasing Adult Hippocampal Neurogenesis is Sufficient to Reduce Anxiety and Depression-Like Behaviors

Hill, A. S., Sahay, A., & Hen, R. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.85 · Cited by 557 · see citing works

Effects of Treatment on Airway Inflammation and Thickening of Basement Membrane Reticular Collagen in Asthma: A Quantitative Light and Electron Microscopic Study

Jeffery, P. K., Godfrey, R. W. A., Adelroth, E. C., Nelson, F., Rogers, A. V., & Johansson, S.-A. (1992) · American Review of Respiratory Disease · doi:10.1164/ajrccm/145.4_pt_1.890 · Cited by 536 · see citing works

Functional Selectivity and Biased Receptor Signaling

Kenakin, T. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.173948 · Cited by 504 · see citing works

The effects of serotonin in immune cells

Herr, N., Bode, C., & Duerschmied, D. (2017) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2017.00048 · Cited by 497 · see citing works

Multiplicity of mechanisms of serotonin receptor signal transduction

Raymond, J. R., Mukhin, Y. V., Gelasco, A. K., Turner, J. H., Collinsworth, G., Gettys, T. W., Grewal, J. S., & Garnovskaya, M. N. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(01)00169-3 · Cited by 466 · see citing works

The Post-Graduate Medical Journal

H., H. B. (1928) · Journal of The Royal Naval Medical Service · doi:10.1136/jrnms-14-70a · Cited by 444 · see citing works

Serotonin has a key role in pathogenesis of experimental colitis.

Ghia, J., Li, N., Wang, H.-Q., Collins, M., Deng, Y.-K., El-Sharkawy, R. T., Côté, F., Mallet, J., & Khan, W. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.08.041 · Cited by 417 · see citing works

Immunobiology of Asthma

Hamid, Q. A., & Tulić, M. K. (2009) · Annual Review of Physiology · doi:10.1146/annurev.physiol.010908.163200 · Cited by 377 · see citing works

The Immune System in Health and Disease

Janeway, C. A., Travers, P. J., Walport, M. J., & Shlomchik, M. J. (2001) · Cited by 374 · see citing works

The role of serotonin and its receptors in activation of immune responses and inflammation

Shajib, M. S., & Khan, W. I. (2014) · Acta Physiologica · doi:10.1111/apha.12430 · Cited by 373 · see citing works

Psychedelics as Medicines: An Emerging New Paradigm

Nichols, D. E., Johnson, M., & Nichols, C. (2016) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.557 · Cited by 373 · see citing works

A REVIEW OF THE CLINICAL EFFECTS OF PSYCHOTOMIMETIC AGENTS

Osmond, H. (1957) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1957.tb40738.x · Cited by 369 · see citing works

Impaired Respiratory and Body Temperature Control Upon Acute Serotonergic Neuron Inhibition

Ray, R. S., Corcoran, A. E., Brust, R. D., Kim, J. C., Richerson, G. B., Nattie, E., & Dymecki, S. M. (2011) · Science · doi:10.1126/science.1205295 · Cited by 363 · see citing works

Pathophysiology of allergic inflammation

Barnes, P. J. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01020.x · Cited by 361 · see citing works

Serotonin provides an accessory signal to enhance T-cell activation by signaling through the 5-HT7 receptor

Leon‐Ponte, M., Ahern, G. P., & O’Connell, P. J. (2006) · Blood · doi:10.1182/blood-2006-10-052787 · Cited by 349 · see citing works

Structure and Function of Serotonin G protein Coupled Receptors

McCorvy, J., & Roth, B. (2015) · Pharmacology and Therapeutics · doi:10.1016/j.pharmthera.2015.01.009 · Cited by 347 · see citing works

Recurrent activating mutations of G-protein-coupled receptor CYSLTR2 in uveal melanoma

Moore, A. R., Ceraudo, E., Sher, J. J., Guan, Y., Shoushtari, A. N., Chang, M. T., Zhang, J. Q., Walczak, E. G., Kazmi, M. A., Taylor, B. S., et al. (2016) · Nature Genetics · doi:10.1038/ng.3549 · Cited by 313 · see citing works

The Physiological Role of 5-HT_2AReceptors in Working Memory

Williams, G. V., Rao, S. G., & Goldman-Rakic, P. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-07-02843.2002 · Cited by 311 · see citing works

Expression and Activity of Histone Deacetylases in Human Asthmatic Airways

Ito, K., Caramori, G., Lim, S., Oates, T., Chung, K. F., Barnes, P. J., & Adcock, I. M. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2110060 · Cited by 306 · see citing works

Pathophysiological Role of Neuroinflammation in Neurodegenerative Diseases and Psychiatric Disorders

Hong, H., Kim, B. S., & Im, H. (2016) · International Neurourology Journal · doi:10.5213/inj.1632604.302 · Cited by 260 · see citing works

Histone Acetylase and Deacetylase Activity in Alveolar Macrophages and Blood Mononocytes in Asthma

Cosío, B. G., Mann, B., Ito, K., Jazrawi, E., Barnes, P. J., Chung, K. F., & Adcock, I. M. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200305-659oc · Cited by 257 · see citing works

Structure–Activity Relationships of One-Ring Psychotomimetics

Shulgin, A. T., Sargent, T., & Naranjo, C. A. (1969) · Nature · doi:10.1038/221537a0 · Cited by 244 · see citing works

Strategies to Discover Unexpected Targets for Drugs Active at G Protein–Coupled Receptors

Allen, J. A., & Roth, B. L. (2011) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010510-100553 · Cited by 216 · see citing works

5-Hydroxytryptamine modulates cytokine and chemokine production in LPS-primed human monocytes via stimulation of different 5-HTR subtypes

Dürk, T., Panther, E., Müller, T., Sorichter, S., Ferrari, D., Pizzirani, C., Virgilio, F. D., Myrtek, D., Norgauer, J., & Idzko, M. (2005) · International Immunology · doi:10.1093/intimm/dxh242 · Cited by 213 · see citing works

Serotonin 5-Hydroxytryptamine2A Receptor Activation Suppresses Tumor Necrosis Factor-α-Induced Inflammation with Extraordinary Potency

Yu, B., Becnel, J., Zerfaoui, M., Rohatgi, R., Boulares, A. H., & Nichols, C. D. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.143461 · Cited by 211 · see citing works

Epigenetic regulation of airway inflammation

Adcock, I. M., Tsaprouni, L., Bhavsar, P. K., & Ito, K. (2007) · Current Opinion in Immunology · doi:10.1016/j.coi.2007.07.016 · Cited by 207 · see citing works

Serotonergic inhibition of catecholamine-induced behavioral arousal

Mabry, P. D., & Campbell, B. A. (1973) · Brain Research · doi:10.1016/0006-8993(73)90429-0 · Cited by 201 · see citing works

Overview on 5-HT receptors and their role in physiology and pathology of the central nervous system

Filip, M., & Bäder, M. (2009) · Pharmacological Reports · doi:10.1016/s1734-1140(09)70132-x · Cited by 199 · see citing works

Serotonin 5-HT2A Receptor Activation Blocks TNF-α Mediated Inflammation In Vivo

Nau, F., Yu, B.-N., Martin, D. A., & Nichols, C. D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075426 · Cited by 197 · see citing works

A Role for Serotonin (5-HT) in Hepatic Stellate Cell Function and Liver Fibrosis

Ruddell, R. G., Oakley, F., Hussain, Z., Yeung, I., Bryan‐Lluka, L. J., Ramm, G. A., & Mann, D. A. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.050767 · Cited by 195 · see citing works

Pharmacological reduction of mucosal but not neuronal serotonin opposes inflammation in mouse intestine

Margolis, K. G., Stevanovic, K. D., Li, Z., Yang, Q., Oravecz, T., Zambrowicz, B., Jhaver, K. G., Diacou, A., & Gershon, M. D. (2013) · Gut · doi:10.1136/gutjnl-2013-304901 · Cited by 192 · see citing works

Examining the role of neuroinflammation in major depression

Furtado, M., & Katzman, M. A. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2015.06.009 · Cited by 191 · see citing works

Functions of 5-HT2A receptor and its antagonists in the cardiovascular system

Nagatomo, T., Rashid, M., Muntasir, H. A., & Komiyama, T. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.08.005 · Cited by 186 · see citing works

Trichostatin A attenuates airway inflammation in mouse asthma model

Choi, J., Oh, S. ‐., Kang, M., Kwon, H. J., Oh, G. T., & Kim, D. Y. (2004) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2004.02006.x · Cited by 183 · see citing works

Serotonin Mediates Oxidative Stress and Mitochondrial Toxicity in a Murine Model of Nonalcoholic Steatohepatitis

Nocito, A., Dahm, F., Jochum, W., Jang, J. H., Georgiev, P., Bäder, M., Renner, E. L., & Clavien, P. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.05.019 · Cited by 175 · see citing works

Serotonin Inhibits Voltage-Gated K + Currents in Pulmonary Artery Smooth Muscle Cells

Cogolludo, A. L., Moreno, L., Lodi, F., Frazziano, G., Cobeño, L., Tamargo, J. L., & Pérez‐Vizcaíno, F. (2006) · Circulation Research · doi:10.1161/01.res.0000216858.04599.e1 · Cited by 175 · see citing works

The alkaloids of Banisteriopsis caapi, the plant source of the Amazonian hallucinogen Ayahuasca, stimulate adult neurogenesis in vitro

Morales-García, J. A., de la Fuente Revenga, M., Alonso-Gil, S., Rodríguez-Franco, M. I., Feilding, A., Perez-Castillo, A., & Riba, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-05407-9 · Cited by 175 · see citing works

New insights from structural biology into the druggability of G protein-coupled receptors

Mason, J. S., Bortolato, A., Congreve, M., & Marshall, F. H. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.02.005 · Cited by 171 · see citing works

Differential effect of serotonin on cytokine production in lipopolysaccharide-stimulated human peripheral blood mononuclear cells: involvement of 5-hydroxytryptamine2A receptors

Cloëz-Tayarani, I. (2003) · International Immunology · doi:10.1093/intimm/dxg027 · Cited by 162 · see citing works

Methysergide for Prevention of Headache

Graham, J. R. (1964) · New England Journal of Medicine · doi:10.1056/nejm196401092700202 · Cited by 161 · see citing works

Psychedelic Drugs in Biomedicine

Kyzar, E. J., Nichols, C. D., Gainetdinov, R. R., Nichols, D. E., & Kalueff, A. V. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.08.003 · Cited by 155 · see citing works

Neuroinflammation drives anxiety and depression in relapsing-remitting multiple sclerosis

Rossi, S., Studer, V., Motta, C., Polidoro, S., Perugini, J., Macchiarulo, G., Giovannetti, A., Pareja-Gutierrez, L., Calò, A., Colonna, I., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000004411 · Cited by 151 · see citing works

Comparison of Airway Remodeling in Acute, Subacute, and Chronic Models of Allergic Airways Disease

Locke, N. R., Royce, S. G., Wainewright, J. S., Samuel, C. S., & Tang, M. L. K. (2007) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2006-0083oc · Cited by 150 · see citing works

Effects of serotonin and serotonergic agonists and antagonists on the production of tumor necrosis factor α and interleukin-6

Kubera, M., Maes, M. H. J., Kenis, G., Kim, Y., & Lasoń, W. (2005) · Psychiatry Research · doi:10.1016/j.psychres.2004.01.014 · Cited by 146 · see citing works

Asthma and COPD : Basic Mechanisms and Clinical Management

Barnes, P. J. (2002) · Cited by 145 · see citing works

Role of serotonin in the action of atypical antipsychotic drugs.

Hy, M. (1995) · PubMed · Cited by 145 · see citing works

Effect of High Dose Inhaled Fluticasone Propionate on Airway Inflammation in Asthma

Booth, H., Richmond, I., Ward, C., Gardiner, P. V., Harkawat, R., & Walters, E. H. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.152.1.7599861 · Cited by 142 · see citing works

Macrophages in allergic asthma: fine-tuning their pro- and anti-inflammatory actions for disease resolution

Moreira, A. P., & Hogaboam, C. M. (2011) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2011.0027 · Cited by 139 · see citing works

mRNA Expression of Serotonin Receptors in Cells of the Immune Tissues of the Rat

Štefulj, J., Jernej, B., Čičin‐Šain, L., Rinner, I., & Schauenstein, K. (2000) · Brain Behavior and Immunity · doi:10.1006/brbi.1999.0579 · Cited by 131 · see citing works

Serotonin Activates Human Monocytes and Prevents Apoptosis

Soga, F., Katoh, N., Inoue, T., & Kishimoto, S. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700824 · Cited by 122 · see citing works

Serotonin Metabolism Is Dysregulated in Cholangiocarcinoma, which Has Implications for Tumor Growth

Alpini, G. D., Invernizzi, P., Gaudio, E., Venter, J. K., Kopriva, S. E., Bernuzzi, F., Onori, P., Franchitto, A., Coufal, M., Frampton, G. A., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2133 · Cited by 120 · see citing works

On the in vivo and in vitro actions of fenfluramine and its derivatives on central monoamine neurons, especially 5-hydroxytryptamine neurons, and their relation to the anorectic activity of fenfluramine.

Fuxé, K., Farnebo, L.-O., Hamberger, B., & Ögren, S. O. (1975) · PubMed · Cited by 120 · see citing works

5-HT2A Receptor Induces ERK Phosphorylation and Proliferation through ADAM-17 Tumor Necrosis Factor-α-converting Enzyme (TACE) Activation and Heparin-bound Epidermal Growth Factor-like Growth Factor (HB-EGF) Shedding in Mesangial Cells

Gooz, M. B., Göőz, P., Luttrell, L. M., & Raymond, J. R. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512096200 · Cited by 119 · see citing works

Innate immune cells in asthma

Deckers, J., Branco‐Madeira, F., & Hammad, H. (2013) · Trends in Immunology · doi:10.1016/j.it.2013.08.004 · Cited by 116 · see citing works

Serotonin 5-HT2A Receptors: Molecular Biology and Mechanisms of Regulation

Roth, B. L., Berry, S. A., Kroeze, W. K., Willins, D. L., & Kristiansen, K. (1998) · Critical Reviews in Neurobiology · doi:10.1615/critrevneurobiol.v12.i4.30 · Cited by 114 · see citing works

Role of serotonin in the pathogenesis of acute and chronic pulmonary hypertension

Egermayer, P., Town, G. I., & Peacock, A. (1999) · Thorax · doi:10.1136/thx.54.2.161 · Cited by 114 · see citing works

Proliferation and Signaling in Fibroblasts

Welsh, D., Harnett, M. M., MacLean, M. R., & Peacock, A. J. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200302-264oc · Cited by 112 · see citing works

Serotonin synthesis inhibition and estrous behavior in female rats

Meyerson, B. J., & Lewander, T. (1970) · Life Sciences · doi:10.1016/0024-3205(70)90195-5 · Cited by 110 · see citing works

Serotonergic Dysfunction in Parkinson's Disease and Its Relevance to Disability

Politis, M., & Loane, C. (2011) · The Scientific World JOURNAL · doi:10.1100/2011/172893 · Cited by 109 · see citing works

Further evidence for an inhibitory role of central 5-HT in male rat sexual behavior

Ahlénius, S., Larsson, K., & Svensson, L. (1980) · Psychopharmacology · doi:10.1007/bf00428106 · Cited by 106 · see citing works

Mescaline use for 5700 years

Bruhn, J. G., Smet, P. A. G. M. D., El-Seedi, H. R., & Beck, O. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08701-9 · Cited by 104 · see citing works

Antinociceptive activity of morphine after injection of biogenic amines in the cerebral ventricles of the conscious rat

Sparkes, C. G., & Spencer, P. S. J. (1971) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1971.tb07104.x · Cited by 97 · see citing works

Serotonin Increases Interleukin-6 Synthesis in Human Vascular Smooth Muscle Cells

Ito, T., Ikeda, U., Shimpo, M., Yamamoto, K., & Shimada, K. (2000) · Circulation · doi:10.1161/01.cir.102.20.2522 · Cited by 97 · see citing works

TNF can contribute to multiple features of ovalbumin-induced allergic inflammation of the airways in mice

Nakae, S., Lunderius, C., Ho, L. H., Schäfer, B., Tsai, M. M., & Galli, S. J. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.11.701 · Cited by 93 · see citing works

Serotonin 5-HT2 receptor activation prevents allergic asthma in a mouse model

Nau, F., Miller, J., Saravia, J., Ahlert, T. A., Yu, B.-N., Happel, K., Cormier, S., & Nichols, C. D. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00138.2013 · Cited by 91 · see citing works

Integrated Approaches for Genome-wide Interrogation of the Druggable Non-olfactory G Protein-coupled Receptor Superfamily

Roth, B. L., & Kroeze, W. K. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.r115.654764 · Cited by 88 · see citing works

Structure–activity relationships of serotonin 5‐HT2Aagonists

Nichols, D. E. (2012) · Wiley Interdisciplinary Reviews Membrane Transport and Signalling · doi:10.1002/wmts.42 · Cited by 82 · see citing works

The effect of ondansetron on cognitive performance in the marmoset

Domeney, A. M., Costall, B., Gerrard, P. A., Jones, D. N. C., Naylor, R. J., & Tyers, M. B. (1991) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(91)90606-3 · Cited by 82 · see citing works

Biologics in Asthma—The Next Step Toward Personalized Treatment

Darveaux, J. I., & Busse, W. W. (2015) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2014.09.014 · Cited by 81 · see citing works

Serotonin inhibition of tumor necrosis factor-α synthesis by human monocytes

ARZT, E. S., Costas, M. A., Finkielman, S., & Nahmod, V. E. (1991) · Life Sciences · doi:10.1016/0024-3205(91)90612-f · Cited by 80 · see citing works

Ueber Pellote

Heffter, A. (1898) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf01825267 · Cited by 77 · see citing works

Modulation of cardiovascular and electrocortical activity through serotonergic mechanisms in the nucleus tractus solitarius of the rat

Laguzzi, R. F., Reis, D. J., & Talman, W. T. (1984) · Brain Research · doi:10.1016/0006-8993(84)90336-6 · Cited by 76 · see citing works

Modulating Neuroinflammation to Treat Neuropsychiatric Disorders

Radtke, F., Chapman, G., Hall, J., & Syed, Y. A. (2017) · BioMed Research International · doi:10.1155/2017/5071786 · Cited by 76 · see citing works

Are serotonergic neurons involved in the control of anxiety and in the anxiolytic activity of benzodiazepines?

Thiébot, M.-H. (1986) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(86)90214-5 · Cited by 74 · see citing works

Common receptors for hallucinogens in rat brain: a comparative autoradiographic study using [125I]LSD and [125I]DOI, a new psychotomimetic radioligand

McKenna, D. J., Nazarali, A. J., Hoffman, A. J., Nichols, D. E., Mathis, C. A., & Saavedra, J. M. (1989) · Brain Research · doi:10.1016/0006-8993(89)91535-7 · Cited by 70 · see citing works

Modulation of airway hyperresponsiveness and eosinophilia by selective histamine and 5‐HT receptor antagonists in a mouse model of allergic asthma

Bie, J. J. D., Henricks, P. A. J., Cruikshank, W. W., Hofman, G. A., Jonker, E. H., Nijkamp, F. P., & van Oosterhout, A. J. M. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701901 · Cited by 68 · see citing works

Therapeutic effects of histone deacetylase inhibitors in a murine asthma model

Ren, Y., Su, X., Kong, L., Li, M., Zhao, X., Yu, N., & Kang, J. (2016) · Inflammation Research · doi:10.1007/s00011-016-0984-4 · Cited by 68 · see citing works

Activity and expression of histone acetylases and deacetylases in inflammatory phenotypes of asthma

Gunawardhana, L. P., Gibson, P. G., Simpson, J. L., Powell, H. A., & Baines, K. J. (2013) · Clinical & Experimental Allergy · doi:10.1111/cea.12168 · Cited by 65 · see citing works

Serotonin activates murine alveolar macrophages through 5-HT2Creceptors

Mikulski, Z., Zasłona, Z., Cakarova, L., Hartmann, P., Wilhelm, J., Tecott, L. H., Lohmeyer, J., & Kummer, W. (2010) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00032.2010 · Cited by 65 · see citing works

Regulation of antigen-specific CTL and Th1 cell activation through 5-Hydroxytryptamine 2A receptor

Inoue, M., Okazaki, T., Kitazono, T., Mizushima, M., Omata, M., & Ozaki, S. (2010) · International Immunopharmacology · doi:10.1016/j.intimp.2010.10.007 · Cited by 59 · see citing works

Epigenetic Mechanisms of Serotonin Signaling

Holloway, T. D., & González‐Maeso, J. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00033 · Cited by 59 · see citing works

Expression of the 5-HT2A Serotoninergic Receptor in Human Placenta and Choriocarcinoma Cells: Mitogenic Implications of Serotonin

Sonier, B., Lavigne, C., Arseneault, M., Ouellette, R. J., & Vaillancourt, C. (2004) · Placenta · doi:10.1016/j.placenta.2004.08.003 · Cited by 59 · see citing works

Regulation of Serotonin-Induced Trafficking and Migration of Eosinophils

Kang, B., Ha, S., Bahaie, N. S., Hosseinkhani, M., Ge, X.-N., Blumenthal, M., Rao, S. P., & Sriramarao, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054840 · Cited by 56 · see citing works

A New Hallucinogen: 3,4,5-Trimethoxyphenyl-β-Aminopropane

Peretz, D. I., Smythies, J., & Gibson, W. C. (1955) · Journal of Mental Science · doi:10.1192/bjp.101.423.317 · Cited by 55 · see citing works

Role of Central 5-HT2 Receptors in Fluoxetine-Induced Decreases in T Lymphocyte Activity

Pellegrino, T. C., & Bayer, B. (2002) · Brain Behavior and Immunity · doi:10.1006/brbi.2001.0625 · Cited by 54 · see citing works

Characterization of the Serotonin Receptor Mediating Contraction in the Mouse Thoracic Aorta and Signal Pathway Coupling

McKune, C. M., & Watts, S. W. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29514-8 · Cited by 52 · see citing works

Discriminative stimulus properties of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane [(±)DOI] in C57BL/6J mice

Smith, R. L., Barrett, R. J., & Sanders‐Bush, E. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1252-6 · Cited by 48 · see citing works

Serotonin responsiveness through 5-HT2A and 5-HT4 receptors is differentially regulated in hypertrophic and failing rat cardiac ventricle

Brattelid, T., Qvigstad, E., Birkeland, J. A. K., Swift, F., Bekkevold, S. V., Krobert, K. A., Sejersted, O. M., Skomedal, T., Osnes, J., Levy, F. O., et al. (2007) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2007.08.019 · Cited by 47 · see citing works

5-Hydroxytryptamine-induced synovial plasma extravasation is mediated via 5-hydroxytryptamine2A receptors on sympathetic efferent terminals.

Pierce, P. A., Xie, G. X., Peroutka, S. J., Green, P. G., & Levine, J. D. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12078-8 · Cited by 46 · see citing works

How much do we know about the coupling of G-proteins to serotonin receptors?

Giulietti, M., Vivenzio, V., Piva, F., Principato, G., Bellantuono, C., & Nardi, B. (2014) · Molecular Brain · doi:10.1186/s13041-014-0049-y · Cited by 46 · see citing works

Inflammation, Allergy and Asthma, Complex Immune Origin Diseases: Mechanisms and Therapeutic Agents

Suresh Ramnath, N. A. I. K., & Wala, S. M. (2012) · Recent Patents on Inflammation & Allergy Drug Discovery · doi:10.2174/187221313804004682 · Cited by 46 · see citing works

Serotonin 5- Receptor Function as a Contributing Factor to Both Neuropsychiatric and Cardiovascular Diseases

Nichols, C. D. (2009) · Cardiovascular Psychiatry and Neurology · doi:10.1155/2009/475108 · Cited by 43 · see citing works

Characterization of serotonin binding sites on human platelets

McBride, P., Mann, J. J., McEwen, B. S., & Biegon, A. R. (1983) · Life Sciences · doi:10.1016/0024-3205(83)90743-9 · Cited by 43 · see citing works

Serotonin-activated signal transduction via serotonin receptors on Jurkat cells.

Aune, T. M., Kelley, K. A., Ranges, G. E., & Bombara, M. P. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.6.1826 · Cited by 41 · see citing works

Airway and lung elastic fibre is not reduced in asthma nor in asthmatics following corticosteroid treatment

Godfrey, R. W. A., Lorimer, S. M., Majumdar, S., Adelroth, E. C., Johnston, P., Rogers, A., Johansson, S.-A., & Jeffery, P. (1995) · European Respiratory Journal · doi:10.1183/09031936.95.08060922 · Cited by 41 · see citing works

Binding to the serotonin 5-HT2 receptor by the enantiohers of 125I-DOI

Johnson, M. P., Hoffman, A. J., Nichols, D. E., & Mathis, C. A. (1987) · Neuropharmacology · doi:10.1016/0028-3908(87)90138-9 · Cited by 41 · see citing works

International European Respiratory Society/American Thoracic Society guidelines on severe asthma

Chung, K. F., & Wenzel, S. E. (2014) · European Respiratory Journal · doi:10.1183/09031936.00120714 · Cited by 40 · see citing works

THE ROLE OF ENDOGENOUS SEROTONIN IN ADJUVANT-INDUCED ARTHRITIS IN THE RAT

Harbuz, M. S., PERVEEN-GILL, Z., Lalies, M. D., Jessop, D. S., Lightman, S. L., & Chowdrey, H. S. (1996) · Lara D. Veeken · doi:10.1093/rheumatology/35.2.112 · Cited by 40 · see citing works

A holistic view of GPCR signaling

Kenakin, T. (2010) · Nature Biotechnology · doi:10.1038/nbt0910-928 · Cited by 38 · see citing works

Insights into Serotonin Receptor Trafficking

Darmon, M. C., Awabdh, S. A., Emerit, M. B., & Masson, J. (2015) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2015.02.009 · Cited by 34 · see citing works

The Pathologic and Clinical Intersection of Atopic and Autoimmune Disease

Shah, A. (2012) · Current Allergy and Asthma Reports · doi:10.1007/s11882-012-0293-0 · Cited by 33 · see citing works

Inflammation, Allergy and Asthma, Complex Immune Origin Diseases: Mechanisms and Therapeutic Agents

Suresh Ramnath, N. A. I. K., & Wala, S. M. (2012) · Recent Patents on Inflammation & Allergy Drug Discovery · doi:10.2174/1872213x11307010062 · Cited by 32 · see citing works

Wishing Away Inflammation? New Links between Serotonin and TNF Signaling

Pelletier, M., & Siegel, R. M. (2009) · Molecular Interventions · doi:10.1124/mi.9.6.5 · Cited by 29 · see citing works

In vitro immunopotentiating properties and tumour cell toxicity induced by Lophophora williamsii (peyote) cactus methanolic extract

Franco-Molina, M. Á., Gomez‐Flores, R., Tamez‐Guerra, P., Tamez‐Guerra, R., Castillo-León, L., & Rodrı́guez-Padilla, C. (2003) · Phytotherapy Research · doi:10.1002/ptr.1313 · Cited by 29 · see citing works

Alteration of central serotonin modifies onset and severity of adjuvant- induced arthritis in the rat

Harbuz, M. S. (1998) · British journal of rheumatology · doi:10.1093/rheumatology/37.10.1077 · Cited by 29 · see citing works

SEROTONIN 5HT2A RECEPTOR ACTIVATION INHIBITS INDUCIBLE NITRIC OXIDE SYNTHASE ACTIVITY IN C6 GLIOMA CELLS

Miller, K. J., Mariano, C. L., & Cruz, W. R. (1997) · Life Sciences · doi:10.1016/s0024-3205(97)00806-0 · Cited by 27 · see citing works

Induction of Indefinite Survival of Fully Mismatched Cardiac Allografts and Generation of Regulatory Cells by Sarpogrelate Hydrochloride

Akiyoshi, T., Zhang, Q., Inoue, F., Aramaki, O., Hatano, M., Shimazu, M., Kitajima, M., Shirasugi, N., & Niimi, M. (2006) · Transplantation · doi:10.1097/01.tp.0000233870.54297.9a · Cited by 27 · see citing works

Effects of 5-HT2A Receptor Stimulation and Blocking on Immune Response

Давыдова, С. М., Чейдо, М. А., Gevorgyan, M. M., & Idova, G. V. (2010) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-010-1109-7 · Cited by 24 · see citing works

Serotonin 5‐HT2A Receptor Activation Inhibits Cytokine‐stimulated Inducible Nitric Oxide Synthase in C6 Glioma Cellsa

Miller, K. J., & GONZALEZ, H. A. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb10188.x · Cited by 24 · see citing works

Serotonin regulates amylase secretion and acinar cell damage during murine pancreatitis

Sonda, S., Silva, A. B., Grabliauskaite, K., Saponara, E., Weber, A., Jang, J., Züllig, R., Bain, M., Graf, T. R., Hehl, A. B., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-301724 · Cited by 23 · see citing works

Naftidrofuryl-driven regulation of endothelial ICAM-1 involves nitric oxide

Marconi, A., Darquenne, S., Boulmerka, A., Mosnier, M., & d’Alessio, P. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)01368-0 · Cited by 22 · see citing works

1 Rhodopsin Mutations in Congenital Night Blindness

McAlear, S. D., Kraft, T. W., & Gross, A. K. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-1399-9_30 · Cited by 21 · see citing works

Biologics in the treatment of severe asthma

Quirce, S., Phillips‐Anglés, E., Domínguez‐Ortega, J., & Barranco, P. (2017) · Allergologia et Immunopathologia · doi:10.1016/j.aller.2017.09.012 · Cited by 20 · see citing works

The Role of 5-HT Dysregulation in Inflammatory Bowel Disease.

Khan, W. I. (2013) · PubMed · Cited by 12 · see citing works

When the immune system goes on the attack

Brower, V. (2004) · EMBO Reports · doi:10.1038/sj.embor.7400217 · Cited by 10 · see citing works

Gastroenterology and Hepatology

Goel, K., Carachi, R., & Bhutta, Z. A. (2012) · Jaypee Brothers Medical Publishers (P) Ltd. eBooks · doi:10.5005/jp/books/11591_7 · Cited by 10 · see citing works

Whole blood serotonin levels in chronic renal failure

Steyn, M., Viljoen, M., Ubbink, J. B., Rensburg, B. W. J. V., & Reinach, S. G. (1992) · Life Sciences · doi:10.1016/0024-3205(92)90588-g · Cited by 8 · see citing works

[Suppression of sleep and decrease of cerebral serotonin caused by lesion of the raphe system in the cat].

Jouvet, M., Bobillier, P., Pujol, J. F., & Renault, J. (1967) · PubMed · Cited by 7 · see citing works

The synthesis of a new homologue of mescaline.

HEY, P. (2010) · PubMed · Cited by 5 · see citing works

Cases Seen in the Wards, Oct. 22nd, 1925

Symonds, C. P. (1925) · Postgraduate Medical Journal · doi:10.1136/pgmj.1.3.35 · Cited by 3 · see citing works

Psychedelics reopen the social reward learning critical period

Nardou, R., Sawyer, E., Song, Y. J., Wilkinson, M., Padovan-Hernandez, Y., de Deus, J. L., Wright, N., Lama, C., Faltin, S., Goff, L. A., et al. (2023) · Nature · doi:10.1038/s41586-023-06204-3 · Cited by 358 · see citing works

Cessation and reduction in alcohol consumption and misuse after psychedelic use

Garcia‐Romeu, A., Davis, A. K., Erowid, F., Erowid, E., Griffiths, R. R., & Johnson, M. W. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119845793 · Cited by 287 · see citing works

Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms

Inserra, A., De Gregorio, D., & Gobbi, G. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000056 · Cited by 232 · see citing works

Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey

Garcia‐Romeu, A., Davis, A. K., Erowid, E., Erowid, F., Griffiths, R. R., & Johnson, M. W. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00955 · Cited by 157 · see citing works

Pivotal mental states

Brouwer, A., & Carhart-Harris, R. L. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881120959637 · Cited by 159 · see citing works

Inflammatory signaling mechanisms in bipolar disorder

Jones, G. H., Vecera, C. M., Pinjari, O. F., & Machado‐Vieira, R. (2021) · Journal of Biomedical Science · doi:10.1186/s12929-021-00742-6 · Cited by 141 · see citing works

Changes in inflammatory biomarkers are related to the antidepressant effects of Ayahuasca

Galvão-Coelho, N. L., de Menezes Galvão, A. C., de Almeida, R. N., Palhano-Fontes, F., Campos Braga, I., Lobão Soares, B., Maia-de-Oliveira, J. P., Perkins, D., Sarris, J., & de Araujo, D. B. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881120936486 · Cited by 128 · see citing works

The clinical pharmacology and potential therapeutic applications of 5‐methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT)

Reckweg, J. T., Uthaug, M. V., Szabó, A., Davis, A. K., Lancelotta, R., Mason, N. L., & Ramaekers, J. G. (2022) · Journal of Neurochemistry · doi:10.1111/jnc.15587 · Cited by 111 · see citing works

Ketamine and Serotonergic Psychedelics: Common Mechanisms Underlying the Effects of Rapid-Acting Antidepressants

Kadriu, B., Greenwald, M., Henter, I. D., Gilbert, J. R., Kraus, C., Park, L. T., & Zarate, C. A. (2021) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaa087 · Cited by 99 · see citing works

Psilocybin induces acute and persisting alterations in immune status in healthy volunteers: An experimental, placebo-controlled study

Mason, N. L., Szabó, A., Kuypers, K. P. C., Mallaroni, P., de la Torre, R., Reckweg, J. T., Tse, D. H. Y., Hutten, N. R. P. W., Feilding, A., & Ramaekers, J. G. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.09.004 · Cited by 89 · see citing works

Depression, mindfulness, and psilocybin: possible complementary effects of mindfulness meditation and psilocybin in the treatment of depression. a review

Heuschkel, K., & Kuypers, K. P. C. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00224 · Cited by 86 · see citing works

Rapid and sustained decreases in suicidality following a single dose of ayahuasca among individuals with recurrent major depressive disorder: results from an open-label trial

Zeifman, R. J., Singhal, N., SANTOS, R. G. D., Sanches, R. F., Osório, F. D. L., Hallak, J. E. C., & Weissman, C. R. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05692-9 · Cited by 83 · see citing works

From psychiatry to neurology: Psychedelics as prospective therapeutics for neurodegenerative disorders

Kozłowska, U., Nichols, C. D., Wiatr, K., & Figiel, M. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15509 · Cited by 80 · see citing works

The Psychedelic Future of Post-Traumatic Stress Disorder Treatment

Zaretsky, T. G., Jagodnik, K. M., Barsic, R., Antonio, J. H., Bonanno, P. A., MacLeod, C., Pierce, C., Carney, H., Morrison, M. T., Saylor, C. F., et al. (2024) · Current Neuropharmacology · doi:10.2174/1570159x22666231027111147 · Cited by 85 · see citing works

5-HT2A receptors: Pharmacology and functional selectivity

Cummins, B. R., Billac, G. B., Nichols, D. E., & Nichols, C. D. (2025) · Pharmacological Reviews · doi:10.1016/j.pharmr.2025.100059 · Cited by 79 · see citing works

Clinical and biological predictors of psychedelic response in the treatment of psychiatric and addictive disorders: A systematic review

Romeo, B., Hermand, M., Pétillion, A., Karila, L., & Benyamina, A. (2021) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2021.03.002 · Cited by 76 · see citing works

Associations between lifetime classic psychedelic use and markers of physical health

Simonsson, O., Sexton, J. D., & Hendricks, P. S. (2021) · Journal of Psychopharmacology · doi:10.1177/0269881121996863 · Cited by 74 · see citing works

Classic Psychedelic Coadministration with Lithium, but Not Lamotrigine, is Associated with Seizures: An Analysis of Online Psychedelic Experience Reports

Nayak, S. M., Gukasyan, N., Barrett, F. S., Erowid, E., Erowid, F., & Griffiths, R. R. (2021) · Pharmacopsychiatry · doi:10.1055/a-1524-2794 · Cited by 74 · see citing works

Psychedelics as an emerging novel intervention in the treatment of substance use disorder: a review

Divito, A. J., & Leger, R. F. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-06009-x · Cited by 75 · see citing works

Neuroinflammatory remodeling of the anterior cingulate cortex as a key driver of mood disorders in gastrointestinal disease and disorders

Matisz, C. E., & Gruber, A. J. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.12.020 · Cited by 70 · see citing works

Psychedelic therapy's transdiagnostic effects: A research domain criteria (RDoC) perspective

Kelly, J. R., Gillan, C. M., Prenderville, J., Kelly, C., Harkin, A., Clarke, G., & O'Keane, V. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.800072 · Cited by 69 · see citing works

Ketamine and serotonergic psychedelics: An update on the mechanisms and biosignatures underlying rapid-acting antidepressant treatment

Johnston, J. N., Kadriu, B., Allen, J., Gilbert, J. R., Henter, I. D., & Zarate, C. A. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109422 · Cited by 68 · see citing works

Classical Psychedelics as Therapeutics in Psychiatry – Current Clinical Evidence and Potential Therapeutic Mechanisms in Substance Use and Mood Disorders

Mertens, L. J., & Preller, K. H. (2021) · Pharmacopsychiatry · doi:10.1055/a-1341-1907 · Cited by 65 · see citing works

Psychedelic‐inspired approaches for treating neurodegenerative disorders

Saeger, H. N., & Olson, D. E. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15544 · Cited by 65 · see citing works

The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder

Rosenblat, J. D., Husain, M. I., Lee, Y. L., McIntyre, R. S., Mansur, R. B., Castle, D. J., Offman, H., Parikh, S. V., Frey, B. N., Schaffer, A., et al. (2022) · The Canadian Journal of Psychiatry · doi:10.1177/07067437221111371 · Cited by 68 · see citing works

MDMA/ecstasy use and psilocybin use are associated with lowered odds of psychological distress and suicidal thoughts in a sample of US adults

Jones, G. M., & Nock, M. K. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811211058923 · Cited by 62 · see citing works

Psychedelics as a Treatment for Alzheimer’s Disease Dementia

Jones, S. V., & O’Kelly, A. (2020) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2020.00034 · Cited by 62 · see citing works

5-HT2 receptor activation alleviates airway inflammation and structural remodeling in a chronic mouse asthma model

Flanagan, T. W., Sebastian, M. N., Battaglia, D. M., Foster, T. P., Cormier, S. A., & Nichols, C. D. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116790 · Cited by 59 · see citing works

Associations between lifetime classic psychedelic use and cardiometabolic diseases

Simonsson, O., Osika, W., Carhart-Harris, R. L., & Hendricks, P. S. (2021) · Scientific Reports · doi:10.1038/s41598-021-93787-4 · Cited by 55 · see citing works

Neuroinflammation and neuroprogression in depression: Effects of alternative drug treatments

Richardson, B., MacPherson, A., & Bambico, F. R. (2022) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2022.100554 · Cited by 56 · see citing works

Serotonergic psychedelics for depression: What do we know about neurobiological mechanisms of action?

Husain, M. I., Ledwos, N., Fellows, E., Baer, J., Rosenblat, J. D., Blumberger, D. M., Mulsant, B. H., & Castle, D. J. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.1076459 · Cited by 50 · see citing works

Could psychedelic drugs have a role in the treatment of schizophrenia? Rationale and strategy for safe implementation

Wolf, G., Singh, S., Blakolmer, K., Lerer, L. A., Lifschytz, T., Heresco-Levy, U., Lotan, A., & Lerer, B. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01832-z · Cited by 33 · see citing works

The Effect of Combined Treatment of Psilocybin and Eugenol on Lipopolysaccharide-Induced Brain Inflammation in Mice

Zanikov, T., Gerasymchuk, M., Gojani, E. G., Robinson, G. I., Asghari, S., Groves, A., Haselhorst, L., Nandakumar, S., Stahl, C., Cameron, M., et al. (2023) · Molecules · doi:10.3390/molecules28062624 · Cited by 50 · see citing works

Structure-Activity Relationship Analysis of Psychedelics in a Rat Model of Asthma Reveals the Anti-Inflammatory Pharmacophore.

Flanagan, T. W., Billac, G. B., Landry, A. N., Sebastian, M. N., Cormier, S., & Nichols, C. D. (2020) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00063 · Cited by 41 · see citing works

Ayahuasca's therapeutic potential: What we know – and what not

Maia, L. O., Daldegan‐Bueno, D., Wießner, I., de Araújo, D. B., & Tófoli, L. F. (2022) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2022.10.008 · Cited by 47 · see citing works

Investigational and Experimental Drugs to Treat Obsessive-Compulsive Disorder

Grassi, G., Cecchelli, C., Vignozzi, L., & Pacini, S. (2021) · Journal of Experimental Pharmacology · doi:10.2147/jep.s255375 · Cited by 44 · see citing works

Effects of a single dose of psilocybin on behaviour, brain 5-HT2A receptor occupancy and gene expression in the pig

Donovan, L. L., Johansen, J. V., Ros, N. F., Jaberi, E., Línnet, K., Johansen, S. S., Ozenne, B., Issazadeh‐Navikas, S., Hansen, H. D., & Knudsen, G. M. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.11.013 · Cited by 44 · see citing works

Self-Medication for Chronic Pain Using Classic Psychedelics: A Qualitative Investigation to Inform Future Research

Bornemann, J., Close, J. B., Spriggs, M. J., Carhart-Harris, R. L., & Roseman, L. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.735427 · Cited by 43 · see citing works

Effects of repeated lysergic acid diethylamide (LSD) on the mouse brain endocannabinoidome and gut microbiome

Inserra, A., Giorgini, G., Lacroix, S., Bertazzo, A., Choo, J. M., Markopolous, A., Grant, E., Abolghasemi, A., Gregorio, D. D., Flamand, N., et al. (2022) · British Journal of Pharmacology · doi:10.1111/bph.15977 · Cited by 40 · see citing works

Journeying to Ixtlan: Ethics of Psychedelic Medicine and Research for Alzheimer’s Disease and Related Dementias

Peterson, A. H., Largent, E. A., Lynch, H. F., Karlawish, J. H., & Sisti, D. A. (2022) · AJOB Neuroscience · doi:10.1080/21507740.2022.2148771 · Cited by 42 · see citing works

Neuroimaging in psychedelic drug development: past, present, and future

Wall, M. B., Harding, R., Zafar, R. R., Rabiner, E. A., Nutt, D., & Erritzøe, D. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02271-0 · Cited by 41 · see citing works

Evolution of serotonin: sunlight to suicide

Azmitia, E. C. (2020) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-444-64125-0.00001-3 · Cited by 42 · see citing works

Are psychedelics the answer to chronic pain: A review of current literature

Kooijman, N. I., Willegers, T., Reuser, A. M., Mulleners, W. M., Kramers, C., Vissers, K. C. P., & van der Wal, S. E. I. (2023) · Pain Practice · doi:10.1111/papr.13203 · Cited by 43 · see citing works

Psychedelics for acquired brain injury: a review of molecular mechanisms and therapeutic potential

Allen, J., Dames, S., Foldi, C. J., & Shultz, S. R. (2024) · Molecular Psychiatry · doi:10.1038/s41380-023-02360-0 · Cited by 38 · see citing works

Association Between Lifetime Classic Psychedelic Use and Hypertension in the Past Year

Simonsson, O., Hendricks, P. S., Carhart-Harris, R. L., Kettner, H., & Osika, W. (2021) · Hypertension · doi:10.1161/hypertensionaha.120.16715 · Cited by 37 · see citing works

Psilocybin, a Naturally Occurring Indoleamine Compound, Could Be Useful to Prevent Suicidal Behaviors

Strumila, R., Nobile, B., Korsakova, L., Lengvenytė, A., Olié, É., López‐Castromán, J., Guillaume, S., & Courtet, P. (2021) · Pharmaceuticals · doi:10.3390/ph14121213 · Cited by 37 · see citing works

Psychedelics for treatment resistant depression: are they game changers?

Kalfas, M., Taylor, R. H., Tsapekos, D., & Young, A. H. (2023) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2023.2281582 · Cited by 37 · see citing works

Scoping Review: The Role of Psychedelics in the Management of Chronic Pain

Robinson, C. L., Fonseca, A., Diejomaoh, E. M., D'Souza, R. S., Schatman, M. E., Orhurhu, V., & Emerick, T. D. (2024) · Journal of Pain Research · doi:10.2147/jpr.s439348 · Cited by 38 · see citing works

Psychedelics for Brain Injury: A Mini-Review

Khan, M., Carter, G. T., Aggarwal, S. K., & Holland, J. A. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.685085 · Cited by 37 · see citing works

Self-Entropic Broadening Theory: Toward a New Understanding of Self and Behavior Change Informed by Psychedelics and Psychosis

Dourron, H. M., Strauss, C. K., & Hendricks, P. S. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000514 · Cited by 31 · see citing works

Trends in the Top-Cited Articles on Classic Psychedelics

Lawrence, D. W., Sharma, B., Griffiths, R. R., & Carhart-Harris, R. (2021) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2021.1874573 · Cited by 35 · see citing works

Psychedelics in neuroinflammation: Mechanisms and therapeutic potential

de Deus, J. L., Maia, J. M., Soriano, R. N., Amorim, M. R., & Branco, L. G. S. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111278 · Cited by 34 · see citing works

The Safety and Efficacy of Psychedelic-Assisted Therapies for Older Adults: Knowns and Unknowns

Johnston, C. B., Mangini, M., Grob, C. S., & Anderson, B. T. (2022) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2022.08.007 · Cited by 33 · see citing works

Psychedelics as Novel Therapeutics in Alzheimer’s Disease: Rationale and Potential Mechanisms

Garcia‐Romeu, A., Darcy, S., Jackson, H., White, T., & Rosenberg, P. B. (2021) · Current topics in behavioral neurosciences · doi:10.1007/7854_2021_267 · Cited by 31 · see citing works

Psychedelics for alzheimer's disease-related dementia: Unveiling therapeutic possibilities and pathways

Sinha, J. K., Trisal, A., Ghosh, S., Gupta, S., Singh, D. K. K., Han, S. S., Mahapatra, M., Abomughaid, M. M., Abomughayedh, A. M., Almutary, A. G., et al. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102211 · Cited by 31 · see citing works

Psilocybin-assisted psychotherapy for depression: Emerging research on a psychedelic compound with a rich history

Pearson, C., Siegel, J. S., & Gold, J. A. (2021) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2021.120096 · Cited by 31 · see citing works

Are Psychedelic Medicines the Reset for Chronic Pain? Preliminary Findings and Research Needs

Zia, F., Baumann, M., Belouin, S., Dworkin, R., Ghauri, M. H., Hendricks, P. S., Henningfield, J., Lanier, R., Ross, S., & Berger, A. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109528 · Cited by 26 · see citing works

Psychedelic Cognition—The Unreached Frontier of Psychedelic Science

Bălăeţ, M. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.832375 · Cited by 30 · see citing works

Psychedelic control of neuroimmune interactions governing fear

Chung, E. N., Lee, J., Polonio, C. M., Choi, J., Akl, C. F., Kilian, M., Weiß, W. M., Gunner, G., Ye, M., Heo, T. H., et al. (2025) · Nature · doi:10.1038/s41586-025-08880-9 · Cited by 33 · see citing works

Beating pain with psychedelics: Matter over mind?

Elman, I., Pustilnik, A. C., & Borsook, D. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.12.005 · Cited by 28 · see citing works

Psychedelics and Anti-inflammatory Activity in Animal Models

Flanagan, T. W., & Nichols, C. D. (2022) · Current topics in behavioral neurosciences · doi:10.1007/7854_2022_367 · Cited by 29 · see citing works

Psychedelics as preventive treatment in headache and chronic pain disorders

Schindler, E. A. D. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109166 · Cited by 29 · see citing works

Potential analgesic effects of psychedelics on select chronic pain conditions: A survey study

Cavarra, M., Mason, N. L., Kuypers, K. P. C., Bonnelle, V., Smith, W., Feilding, A., Kryskow, P., & Ramaekers, J. G. (2023) · European Journal of Pain · doi:10.1002/ejp.2171 · Cited by 29 · see citing works

A Comprehensive Review of the Current Status of the Cellular Neurobiology of Psychedelics

Banushi, B., & Polito, V. (2023) · Biology · doi:10.3390/biology12111380 · Cited by 25 · see citing works

Communalistic use of psychoactive plants as a bridge between traditional healing practices and Western medicine: A new path for the Global Mental Health movement

Oña, G., Berrada, A., & Bouso, J. C. (2021) · Transcultural Psychiatry · doi:10.1177/13634615211038416 · Cited by 29 · see citing works

Psilocybin in Palliative Care: An Update

Whinkin, E., Opalka, M., Watters, C., Jaffe, A., & Aggarwal, S. K. (2023) · Current Geriatrics Reports · doi:10.1007/s13670-023-00383-7 · Cited by 27 · see citing works

The potential of psychedelics for the treatment of Alzheimer's disease and related dementias

Winkelman, M., Szabó, A., & Frecska, E. (2023) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2023.07.003 · Cited by 27 · see citing works

The DMT and Psilocin Treatment Changes CD11b+ Activated Microglia Immunological PhenotypePreprint

Kozłowska, U., Klimczak, A., Wiatr, K., & Figiel, M. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.07.434103 · Cited by 27 · see citing works

1-(2,5-Dimethoxy-4-iodophenyl)-2-aminopropane (DOI): From an Obscure to Pivotal Member of the DOX Family of Serotonergic Psychedelic Agents – A Review

Glennon, R. A., & Dukat, M. (2024) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.4c00157 · Cited by 26 · see citing works

Psilocin, the Psychoactive Metabolite of Psilocybin, Modulates Select Neuroimmune Functions of Microglial Cells in a 5-HT2 Receptor-Dependent Manner

Wiens, K. R., Brooks, N. A. H., Riar, I., Greuel, B. K., Lindhout, I. A., & Klegeris, A. (2024) · Molecules · doi:10.3390/molecules29215084 · Cited by 25 · see citing works

The Missing Piece? A Case for Microglia’s Prominent Role in the Therapeutic Action of Anesthetics, Ketamine, and Psychedelics

VanderZwaag, J., Halvorson, T., Dolhan, K., Šimončičová, E., Ben‐Azu, B., & Tremblay, M. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03772-0 · Cited by 26 · see citing works

Anti-Inflammatory Effects of Serotonin Receptor and Transient Receptor Potential Channel Ligands in Human Small Intestinal Epithelial Cells

Robinson, G. I., Li, D., Wang, B., Zahoruiko, Y., Gerasymchuk, M., Hudson, D., Kovalchuk, O., & Kovalchuk, I. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45080427 · Cited by 24 · see citing works

If the Doors of Perception Were Cleansed, Would Chronic Pain be Relieved? Evaluating the Benefits and Risks of Psychedelics

Dworkin, R. H., Anderson, B. T., Andrews, N., Edwards, R. R., Grob, C. S., Ross, S., Satterthwaite, T. D., & Strain, E. C. (2022) · Journal of Pain · doi:10.1016/j.jpain.2022.05.003 · Cited by 22 · see citing works

The illusion of knowledge in the emerging field of psychedelic research

Oña, G., Kohek, M., & Bouso, J. C. (2022) · New Ideas in Psychology · doi:10.1016/j.newideapsych.2022.100967 · Cited by 22 · see citing works

Bedside to bench: the outlook for psychedelic research

Acero, V. P., Cribas, E. S., Browne, K. D., Rivellini, O. M., Burrell, J. C., O’Donnell, J. C., Das, S., & Cullen, D. K. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1240295 · Cited by 22 · see citing works

Psilocybin-assisted therapy for reducing alcohol intake in patients with alcohol use disorder: protocol for a randomised, double-blinded, placebo-controlled 12-week clinical trial (The QUANTUM Trip Trial)

Jensen, M. E., Stenbæk, D. S., Juul, T. S., Fisher, P. M., Ekstrøm, C. T., Knudsen, G. M., & Fink‐Jensen, A. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-066019 · Cited by 22 · see citing works

Associations between MDMA/ecstasy, classic psychedelics, and suicidal thoughts and behaviors in a sample of U.S. adolescents

Jones, G. M., Arias, D., & Nock, M. K. (2022) · Scientific Reports · doi:10.1038/s41598-022-25658-5 · Cited by 21 · see citing works

Psilocybin and Eugenol Reduce Inflammation in Human 3D EpiIntestinal Tissue

Robinson, G. I., Li, D., Wang, B., Rahman, T., Gerasymchuk, M., Hudson, D., Kovalchuk, O., & Kovalchuk, I. (2023) · Life · doi:10.3390/life13122345 · Cited by 21 · see citing works

The immunomodulatory effects of classical psychedelics: A systematic review of preclinical studies

Low, Z. X. B., Ng, W. S., Lim, E. S. Y., Goh, B. H., & Kumari, Y. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.111139 · Cited by 20 · see citing works

Single-dose psilocybin therapy for alcohol use disorder: Pharmacokinetics, feasibility, safety and efficacy in an open-label study

Jensen, M. E., Stenbæk, D. S., Messell, C., Poulsen, E. D., Varga, T. V., Fisher, P. M., Nielsen, M. K. K., Johansen, S. S., Volkow, N. D., Knudsen, G. M., et al. (2025) · Journal of Psychopharmacology · doi:10.1177/02698811251319457 · Cited by 21 · see citing works

Psilocybin and psilocin regulate microglial immunomodulation and support neuroplasticity via serotonergic and AhR signaling

Laabi, S., LeMmon, C., Vogel, C., Chacon, M., & Jimenez, V. M. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114940 · Cited by 20 · see citing works

Serotonin-2 Receptor Agonists Produce Anti-inflammatory Effects through Functionally Selective Mechanisms That Involve the Suppression of Disease-Induced Arginase 1 Expression

Flanagan, T. W., Foster, T. P., Galbato, T. E., Lum, P. Y., Louie, B., Song, G., Halberstadt, A. L., Billac, G. B., & Nichols, C. D. (2024) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.3c00297 · Cited by 20 · see citing works

The Psilocybin-Telomere Hypothesis: An empirically falsifiable prediction concerning the beneficial neuropsychopharmacological effects of psilocybin on genetic aging

Germann, C. B. (2019) · Medical Hypotheses · doi:10.1016/j.mehy.2019.109406 · Cited by 20 · see citing works

Lysergic acid diethylamide induces increased signalling entropy in rats’ prefrontal cortex

Savino, A., & Nichols, C. D. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15534 · Cited by 19 · see citing works

Macrodosing to microdosing with psychedelics: Clinical, social, and cultural perspectives

Kaypak, A. C., & Raz, A. (2022) · Transcultural Psychiatry · doi:10.1177/13634615221119386 · Cited by 19 · see citing works

The current state of ayahuasca research in animal models: A systematic review

Daldegan‐Bueno, D., Simionato, N. M., Favaro, V. M., & Maia, L. O. (2023) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2023.110738 · Cited by 20 · see citing works

Psychedelics in the Treatment of Headache and Chronic Pain Disorders

Schindler, E. A. D. (2022) · Current topics in behavioral neurosciences · doi:10.1007/7854_2022_365 · Cited by 19 · see citing works

Association between Lifetime Classic Psychedelic Use and Sick Leave in a Population-Based Sample

Mellner, C., Dahlén, M., & Simonsson, O. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph191811353 · Cited by 18 · see citing works

Deciphering psilocybin: Cytotoxicity, anti-inflammatory effects, and mechanistic insights

Laabi, S., LeMmon, C., Vogel, C., Chacon, M., & Jimenez, V. M. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.111753 · Cited by 18 · see citing works

Concurrent stress modulates the acute and post-acute effects of psilocybin in a sex-dependent manner

Farinha‐Ferreira, M., Miranda‐Lourenço, C., Galipeau, C., Lenkei, Z., & Sebastião, A. M. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.110280 · Cited by 18 · see citing works

Immune-brain plasticity underpins stress and affective behaviors

Lee, J., & Wheeler, M. E. (2025) · Neuron · doi:10.1016/j.neuron.2025.11.020 · Cited by 19 · see citing works

Targeting inflammatory signaling in obsessive compulsive disorder: a promising approach

Bhatt, S., Anitha, K., Chellappan, D. K., Mukherjee, D., Shilpi, S., Suttee, A., Gupta, G., Singh, T. G., & Dua, K. (2023) · Metabolic Brain Disease · doi:10.1007/s11011-023-01314-3 · Cited by 17 · see citing works

The potential of 5‐methoxy‐ N,N ‐dimethyltryptamine in the treatment of alcohol use disorder: A first look at therapeutic mechanisms of action

Tap, S. C. (2024) · Addiction Biology · doi:10.1111/adb.13386 · Cited by 16 · see citing works

Chronic pain as an emergent property of a complex system and the potential roles of psychedelic therapies

Armstrong, M., Castellanos, J. P., & Christie, D. (2024) · Frontiers in Pain Research · doi:10.3389/fpain.2024.1346053 · Cited by 17 · see citing works

Psilocybin as a novel treatment for chronic pain

Askey, T., Lasrado, R., Maiarù, M., & Stephens, G. J. (2024) · British Journal of Pharmacology · doi:10.1111/bph.17420 · Cited by 17 · see citing works

The neuroprotective and neuroplastic potential of glutamatergic therapeutic drugs in bipolar disorder

Guglielmo, R., & Hasler, G. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104906 · Cited by 16 · see citing works

Psilocybin: From Psychiatric Pariah to Perceived Panacea

Fonzo, G. A., Wolfgang, A. S., Barksdale, B. R., Krystal, J. H., Carpenter, L. L., Kraguljac, N. V., Grzenda, A. L., McDonald, W. M., Widge, A. S., Rodríguez, C. I., et al. (2025) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20230682 · Cited by 16 · see citing works

The effects of ketamine and classic hallucinogens on neurotrophic and inflammatory markers in unipolar treatment-resistant depression: a systematic review of clinical trials

Rossi, G. N., Hallak, J. E. C., Baker, G. B., Dursun, S. M., & SANTOS, R. G. D. (2022) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-022-01460-2 · Cited by 16 · see citing works

Psychedelic Experience

Lyon, A. (2023) · doi:10.1093/oso/9780198843757.001.0001 · Cited by 17 · see citing works

Females in Psychedelic Research: A Perspective for Advancing Research and Practice

Cohen, Z. Z., & Blest‐Hopley, G. (2025) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.5c00255 · Cited by 15 · see citing works

Psychedelics and Anti-inflammatory Activity in Animal Models

Flanagan, T. W., & Nichols, C. D. (2022) · Current topics in behavioral neurosciences · doi:10.1007/7854_2022_367 · Cited by 29 · see citing works

Serotonin, immune function, and psychedelics as potent anti-inflammatories

Nichols, C. D., & Foster, T. P. (2025) · International review of neurobiology · doi:10.1016/bs.irn.2025.04.011 · Cited by 5 · see citing works

Serotonin-2 Receptor Agonists Produce Anti-inflammatory Effects through Functionally Selective Mechanisms That Involve the Suppression of Disease-Induced Arginase 1 Expression

Flanagan, T. W., Foster, T. P., Galbato, T. E., Lum, P. Y., Louie, B., Song, G., Halberstadt, A. L., Billac, G. B., & Nichols, C. D. (2024) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.3c00297 · Cited by 20 · see citing works

Elucidating Anti‐Inflammatory SAR at the 5‐HT 2A Receptor

Billac, G. B., Flanagan, T. W., & Nichols, C. D. (2020) · The FASEB Journal · doi:10.1096/fasebj.2020.34.s1.06584 · Cited by 2 · see citing works

The next bet for cerebral aneurysms treatment: Psychedelics

Ismail, M., Aljuboori, Z., Muthana, A., Sharma, M., Hoz, S. S., & Andaluz, N. O. (2022) · Surgical Neurology International · doi:10.25259/sni_830_2022 · Cited by 1 · see citing works